Additionally, in the acute and subacute phases of ischemic stroke, EZH2 may be involved in the reduction in BBB disruption, decreasing neuroinflammation and infarct volume, possibly leading to neuroprotection [33,79]. The gene discussed is EZH2; the disease is ischemic stroke.